Patents by Inventor Ibrahim Ragab Nassr EISSA

Ibrahim Ragab Nassr EISSA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC TARGET FACTOR RECEPTOR
    Publication number: 20240082300
    Abstract: Provided is a chimeric target factor receptor capable of activating an antigen-presenting cell such as a dendritic cell in a target-factor-specific manner. The chimeric target factor receptor contains a target factor-binding domain, a transmembrane domain, and an intracellular domain containing a TLR intracellular domain.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 14, 2024
    Applicant: NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
    Inventors: Hideki KASUYA, Yoshinori NAOE, Shigeru MATSUMURA, Ibrahim Ragab Nassr EISSA, Mohamed Abdelmoneim Ahmed ALI MOHAMED
  • COMBINATION DRUG FOR TREATING MALIGNANT TUMOR, PHARMACEUTICAL COMPOSITION FOR TREATING MALIGNANT TUMOR, AND PHARMACEUTICAL COMPOSITION FOR MALIGNANT TUMOR TREATMENT
    Publication number: 20220273739
    Abstract: Provided are a combination drug for treating a malignant tumor, a pharmaceutical composition for treating a malignant tumor, and a pharmaceutical composition for malignant tumor treatment that have an exceptional antitumor effect. A malignant tumor can be treated by a combination drug containing a first medicine that includes an oncolytic virus belonging to the herpes simplex viruses type 1 as an active ingredient, and a second medicine that includes an interferon gene stimulating factor agonist as an active ingredient.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Inventors: Hideki KASUYA, Yoshinori NAOE, Shigeru MATSUMURA, Ibrahim Ragab Nassr EISSA